文献速递母胎医学

利用循环滋养细胞进行囊性纤维化无创产前筛查:检测50种最常见致病变异

Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants.
PubMed 文献 · Prenat Diagn · 2022-12-08

本研究旨在开发基于细胞的無創產前檢測(NIPT)筛查50种最常见囊性纤维化(CF)变异,采集30例接受侵入性诊断的孕妇血样,27例成功获取循环滋养细胞,用片段长度分析和新建的NGS方法检测,27例结果均与侵入性检测一致。

要点

  • 基于循环滋养细胞的NIPT可检测50种最常见CF致病变异。
  • 27例样本中两种方法结果均与侵入性诊断一致。
  • 该检测无需伴侣及先证者样本即可提供可靠结果。

核心结论

  • 基于细胞的NIPT用于CF筛查可提供可靠结果,且无需伴侣和先证者样本。

研究设计与样本

  • 研究采集30例接受侵入性诊断的孕妇血样,其中27例成功获取循环滋养细胞,采用片段长度分析和新建的基于NGS的CF分析方法进行检测。

主要发现

  • 27例中基于细胞的NIPT两种方法均给出结果,且与侵入性检测结果一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries. A maternal blood sample in early pregnancy can provide circulating trophoblasts and offers a DNA source for genetic analysis of both the mother and the fetus. This study aimed to develop a cell-based noninvasive prenatal test (NIPT) to screen for the 50 most common CF variants. METHODS: Blood samples were collected from 30 pregnancies undergoing invasive diagnostics and circulating trophoblasts were harvested in 27. Cystic fibrosis testing was conducted using two different methods: by fragment length analysis and by our newly developed NGS-based CF analysis. RESULTS: In all 27 cases, cell-based NIPT provided a result using both methods in agreement with the invasive test result. CONCLUSION: This study shows that cell-based NIPT for CF screening provides a reliable result without the need for partner- and proband samples.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Jeppesen LD, Lildballe DL, Hatt L, et al. Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants. Prenat Diagn. 2022. PMID: 36447355. doi:10.1002/pd.6276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。